• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有六种主要症状的川崎病患者无反应的风险很高。

Kawasaki disease patients with six principal symptoms have a high risk of being a non-responder.

作者信息

Nomura Yuichi, Arata Michiko, Masuda Kiminori, Koriyama Chihaya, Suruki Nobutaka, Ueno Kentaro, Yoshikawa Hideki, Eguchi Taisuke, Kawano Yoshifumi

机构信息

Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.

出版信息

Pediatr Int. 2012 Feb;54(1):14-8. doi: 10.1111/j.1442-200X.2011.03512.x. Epub 2012 Jan 12.

DOI:10.1111/j.1442-200X.2011.03512.x
PMID:22115193
Abstract

BACKGROUND

A diagnosis of Kawasaki disease (KD) is established using six principal symptoms. Because the principal symptoms are deeply connected with KD, it is thus important to investigate the usefulness of the principal symptoms for evaluating the disease severity of KD.

METHODS

Patients with definite KD or suspicion of KD were retrospectively examined. Blood test data and the incidence of patients who failed to respond to the initial i.v. immunoglobulin treatment (non-responders) were compared between patients with six principal symptoms, including fever of ≤ 4 days, before treatment of KD (six-symptom patients), and those with five or fewer symptoms (five-symptom patients).

RESULTS

The study group of 207 patients who were treated with immunoglobulin consisted of 121 six-symptom patients and 86 five-symptom patients. The six-symptom patients were older and had higher neutrophil proportion and total bilirubin, and lower serum sodium at diagnosis than the five-symptom patients. Although the treatments did not differ between the groups, the six-symptom patients had a higher incidence of non-responders than the five-symptom patients (17% vs 5%; P= 0.008). Logistic regression analysis showed that six-symptom status was related to the risk of being a non-responder (odds ratio [OR], 5.3; 95% confidence interval [95%CI]: 1.6-17.4). This association was still significant after adjustment for the effect of age, neutrophil proportion, and total bilirubin and sodium (OR, 4.4; 95%CI: 1.4-17.3).

CONCLUSIONS

The number of principal symptoms before treatment is a useful guide to KD disease severity. Six-symptom patients have a higher risk of being a non-responder than five-symptom patients.

摘要

背景

川崎病(KD)的诊断基于六种主要症状。由于这些主要症状与KD密切相关,因此研究这些主要症状在评估KD疾病严重程度方面的实用性具有重要意义。

方法

对确诊或疑似KD的患者进行回顾性研究。比较了KD治疗前出现包括≤4天发热在内的六种主要症状的患者(六症状患者)和出现五种或更少症状的患者(五症状患者)的血液检测数据以及对初始静脉注射免疫球蛋白治疗无反应患者(无反应者)的发生率。

结果

接受免疫球蛋白治疗的207例患者研究组中,有121例六症状患者和86例五症状患者。六症状患者在诊断时年龄更大,中性粒细胞比例和总胆红素更高,血清钠更低。尽管两组治疗方法无差异,但六症状患者中无反应者的发生率高于五症状患者(17%对5%;P = 0.008)。逻辑回归分析显示,六症状状态与无反应风险相关(比值比[OR],5.3;95%置信区间[95%CI]:1.6 - 17.4)。在调整年龄、中性粒细胞比例、总胆红素和钠的影响后,这种关联仍然显著(OR,4.4;95%CI:1.4 - 17.3)。

结论

治疗前主要症状的数量是KD疾病严重程度的有用指标。六症状患者比五症状患者成为无反应者的风险更高

相似文献

1
Kawasaki disease patients with six principal symptoms have a high risk of being a non-responder.患有六种主要症状的川崎病患者无反应的风险很高。
Pediatr Int. 2012 Feb;54(1):14-8. doi: 10.1111/j.1442-200X.2011.03512.x. Epub 2012 Jan 12.
2
Guideline-Concordant Treatment of Kawasaki Disease With Immunoglobulin and Aspirin and the Incidence of Coronary Artery Aneurysm.用免疫球蛋白和阿司匹林对川崎病进行指南一致性治疗及冠状动脉瘤的发生率
Clin Pediatr (Phila). 2015 Oct;54(11):1076-80. doi: 10.1177/0009922814566932. Epub 2015 Jan 8.
3
Early Appearance of Principal Symptoms of Kawasaki Disease is a Risk Factor for Intravenous Immunoglobulin Resistance.川崎病主要症状的早期出现是静脉注射免疫球蛋白抵抗的一个危险因素。
Pediatr Cardiol. 2015 Aug;36(6):1159-65. doi: 10.1007/s00246-015-1136-2. Epub 2015 Mar 10.
4
Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.类固醇脉冲疗法对免疫球蛋白抵抗型川崎病的影响。
Arch Dis Child. 2008 Feb;93(2):142-6. doi: 10.1136/adc.2007.126144. Epub 2007 Oct 25.
5
[Improving the diagnosis and therapy of Kawasaki disease].[改善川崎病的诊断与治疗]
Zhonghua Er Ke Za Zhi. 2006 May;44(5):321-3.
6
Kawasaki disease: part II. Complications and treatment.川崎病:第二部分。并发症和治疗。
J Am Acad Dermatol. 2013 Oct;69(4):513.e1-8; quiz 521-2. doi: 10.1016/j.jaad.2013.06.040.
7
[Reply to questions regarding diagnosis and treatment of Kawasaki disease].[关于川崎病诊断与治疗问题的回复]
Zhonghua Er Ke Za Zhi. 2006 May;44(5):337-8.
8
Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.急性川崎病的治疗:重新审视阿司匹林在发热阶段的作用。
Pediatrics. 2004 Dec;114(6):e689-93. doi: 10.1542/peds.2004-1037. Epub 2004 Nov 15.
9
Comparison of Risk of Recrudescent Fever in Children With Kawasaki Disease Treated With Intravenous Immunoglobulin and Low-Dose vs High-Dose Aspirin.比较静脉注射免疫球蛋白和低剂量与高剂量阿司匹林治疗川崎病儿童复发性发热的风险。
JAMA Netw Open. 2020 Jan 3;3(1):e1918565. doi: 10.1001/jamanetworkopen.2019.18565.
10
Infections and Kawasaki disease: implications for coronary artery outcome.感染与川崎病:对冠状动脉转归的影响
Pediatrics. 2005 Dec;116(6):e760-6. doi: 10.1542/peds.2005-0559.